Sensyne Health PLC (LON:SENS – Get Free Report)’s share price fell 33.3% during trading on Wednesday . The company traded as low as GBX 0.16 ($0.00) and last traded at GBX 0.35 ($0.00). 4,449,142 shares were traded during trading, an increase of 29% from the average session volume of 3,449,819 shares. The stock had previously closed at GBX 0.53 ($0.01).
Sensyne Health Price Performance
The company has a debt-to-equity ratio of 6.02, a current ratio of 2.26 and a quick ratio of 2.26. The stock’s fifty day moving average is GBX 0.35 and its 200-day moving average is GBX 0.35. The stock has a market cap of £582,624.00 and a PE ratio of -0.02.
Sensyne Health Company Profile
Sensyne Health plc is a healthcare technology company that creates value from accelerating the discovery and development of new medicines and improving patient care through the analysis of real-world evidence from large databases of anonymised patient data in collaboration with NHS Trusts. These anonymised patient data are ethically sourced in that any analysis of anonymised patient data (and hence the Company’s access to it) must be pre-approved for each programme on a case-by-case basis by the relevant NHS Trusts.
Featured Articles
- Five stocks we like better than Sensyne Health
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Boeing: Why Analysts Think Now’s The Time To Be Brave
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Advanced Micro Devices is Building Momentum with AI: Buy the Dip
- The Most Important Warren Buffett Stock for Investors: His Own
- Can Evolv Stock Recover From Its Massive Self-Inflicted Drop?
Receive News & Ratings for Sensyne Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sensyne Health and related companies with MarketBeat.com's FREE daily email newsletter.